The Effectiveness of Semaglutide for Weight Loss In multiple large clinical trials with thousands of participants, semaglutide 2.4 mg led to substantial weight reduction: In a 68-week study of nearly 2000 adults, those getting semaglutide injections lost 14.9% body weight on average compared to 2.4% with placebo plus lifestyle intervention
Therefore, molecular coupling method was used to further explore the interaction of key active ingredients trilobatin, phlorizin and phloretin with the target protein NLRP3 (PDBID:6NPY)
Clinical trials show tirzepatide produces greater average weight loss than semaglutide
Nausea, nasopharyngitis, diarrhea, upper respiratory tract infection, and headache are also commonly reported side effects
None of these replicate the pharmacological mechanism of semaglutide or tirzepatide, and none should be treated as equivalent